Cargando…
Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[(18)F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
CONTEXT: The correlation between fibrous dysplasia/McCune–Albright syndrome (FD/MAS) skeletal disease burden on Na[(18)F]F positron emission tomography–computed tomography (PET-CT) and serum bone turnover markers (BTMs) was recently described. The effect of treatment on lesional fluoride burden in F...
Autores principales: | van der Bruggen, Wouter, Vriens, Dennis, Meier, Maartje E, Smit, Frits, Winter, Elizabeth M, de Geus-Oei, Lioe-Fee, Appelman-Dijkstra, Natasha M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277209/ https://www.ncbi.nlm.nih.gov/pubmed/33788944 http://dx.doi.org/10.1210/clinem/dgab212 |
Ejemplares similares
-
Corrigendum to: Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
Publicado: (2021) -
Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune‐Albright syndrome: an observational study
por: Meier, Maartje E., et al.
Publicado: (2021) -
Neuropathic-like Pain in Fibrous Dysplasia/McCune-Albright Syndrome
por: Spencer, Tiahna L, et al.
Publicado: (2022) -
McCune-Albright syndrome
por: Dumitrescu, Claudia E, et al.
Publicado: (2008) -
McCune Albright Syndrome
por: Jibbe, Nada, et al.
Publicado: (2020)